Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 14:51:101553.
doi: 10.1016/j.eclinm.2022.101553. eCollection 2022 Sep.

Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: A cross-sectional study

Affiliations

Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: A cross-sectional study

Arulraj Ramakrishnan et al. EClinicalMedicine. .

Abstract

Background: Liver disease is the only major chronic disease and mortality is increasing. Earlier detection of liver fibrosis can reduce progression to cirrhosis and hepatocellular carcinoma. Many studies have reported an increased prevalence in liver fibrosis among adults in urban regions but there are few data in physically active rural populations without attributable metabolic risk factors. This aim of this study is to investigate the prevalence of abnormal liver functions tests (LFTs) and liver fibrosis among adults in a rural population.

Methods: This cross-sectional study included observations from KMCH-NNCD-II (2017) study (n = 907) from a farming village, Nallampatti, located in South India. We assessed lifestyle (occupation, tobacco use and alcohol consumption using AUDIT-C questionnaire), markers for metabolic diseases (obesity, hypertension, diabetes, hypercholesterolemia), LFTs and markers for hepatitis viruses B and C. 901 participants had transient elastography to assess fibrosis. Participants with abnormal LFTs and significant liver fibrosis (F2-F4) underwent additional liver screening (caeruloplasmin, iron studies and autoimmune hepatitis panel). Multiple logistic regression analyses were performed to understand the association of liver fibrosis with lifestyle and metabolic risk factors after adjustment for co-variates.

Findings: Significant liver fibrosis (F2-F4) was observed in 14.4%, and cirrhosis in 0.8%. There was an association of liver fibrosis with abnormal LFTs but no association between alcohol consumption, viral hepatitis, hepatic liver screening and liver fibrosis. Among metabolic risk factors, no association was observed for hypertension and hypercholesterolemia but diabetes [OR - 3.206 (95% CI: 1.792 - 5.736)], obesity [1.987 (1.341 - 2.944)] and metabolic syndrome [2.539 (1.680 - 3.836)] showed association with significant liver fibrosis (F2-F4) after adjustment for confounding factors.

Interpretation: Our results suggest that the prevalence of liver fibrosis in rural population is similar to urban counterparts. The association of metabolic risk factors with liver fibrosis in physically active rural population warrants further investigations in future studies.

Funding: This study is funded by KMCH Research Foundation, India.

Keywords: Abnormal liver tests; Aetiological screening for abnormal LFT's; Elastography screening; Liver fibrosis; Low and middle income country; Metabolic syndrome; prevalence.

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Figures

Figure 1
Figure 1
Stepwise methodology followed for assessment of liver fibrosis and its risk factors in KMCH-NNCD-II study.

Similar articles

Cited by

References

    1. Williams R, Ashton K, Aspinall R, et al. Implementation of the lancet standing commission on liver disease in the UK. Lancet. 2015;386(10008):2098–2111. - PubMed
    1. Harrison P, Hogan BJ, Floros L, Davies E, Guideline Development G. Assessment and management of cirrhosis in people older than 16 years: summary of NICE guidance. BMJ. 2016;354:i2850. - PubMed
    1. Gines P, Graupera I, Lammert F, et al. Screening for liver fibrosis in the general population: a call for action. Lancet Gastroenterol Hepatol. 2016;1(3):256–260. - PubMed
    1. Wilson JMG. World Health Organization; 1968. Jungner, Gunnar, World Health Organization. Principles and Practice of Screening for Disease /J. M. G. Wilson, G. Jungner.https://apps.who.int/iris/handle/10665/37650
    1. McLernon DJ, Donnan PT, Ryder S, et al. Health outcomes following liver function testing in primary care: a retrospective cohort study. Fam Pract. 2009;26(4):251–259. - PubMed

LinkOut - more resources